Variation in baseline estrogen levels, menopause-related adverse events and early study discontinuation among women on the placebo-controlled MAP.3 exemestane prevention trial

ESMO Open · Elsevier

Аннотация

Publication date: November 2026 Source: ESMO Open, Volume 11, Issue 11 Author(s): V. Ho, R. Pasquet, R.J. Singh, M.P. Goetz, D. Tu, J.N. Ingle, H. Richardson, Hugh M.C. Scarth, Louise Provencher, Pierre Dube, Marie-Helen Mayrand, Edgard Nassif, Conrad Falkson, Shailendra Verma, Barry Dworkin, James R. Wright, Yasmin H. Rahim, Angela Cheung, Andrea Eisen, Lavina Lickley

Читать у издателя →

Похожие статьи